• Hereditary Neuroendocrine Tumor Gene Mutation Panel, NGS
  • Chromosome Analysis, Hematologic Disorders, Blood
  • Carnitine Palmitoyltransferase 1A (CPT1A) Mutation Analysis
  • Thyrotropin Releasing Hormone (TRH)
  • 5-Hydroxyindoleacetic Acid (5-HIAA), Urine
  • HER2/neu (ERBB2) Gene Amplification, FISH, Breast Cancer
  • Microsomal epoxide hydrolase 1 (EPHX1) Gene Variation
  • Lorazepam, Serum
  • Bilirubin Total, Body Fluid
  • Lyme Disease (Borrelia burgdorferi) Antibody, IgG, IgM, Immunoblot
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Genetic Testing for Severe Inherited Diseases, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Genetic Testing for Severe Inherited Diseases, NGS
Medical Test

Reference Ranges
Access to Genetic Testing for Severe Inherited Diseases, NGS is restricted.
Loading...